Inside the Anthropic IPO: Valuation, Risks, and Fund Impact

Anthropic ANT is preparing to list on the Nasdaq Global Market, and the headlines are already loud. High-profile IPOs attract more hype than almost any other market event. But does the investment case live up to the buzz?

You’ll hear from:

Malik Ahmed Khan, senior equity analyst, who will outline where we think Anthropic should be priced and whether it has an economic moat, meaning a durable competitive advantage. He’ll also cover our revenue forecast, what it signals about AI adoption, and the key risks investors should weigh.

Dominic Pappalardo, chief multi-asset strategist, on whether the price reflects what the business is worth, why IPO volatility calls for a suitability review before buying, and why long-term outcomes matter more than a short-term “pop.”

Harrison Rolfes, senior research analyst, late-stage company research, PitchBook, on what Anthropic’s S-1 reveals about its compute commitments, founder control, and dilution, and how the company’s private market valuations compare with the reported IPO price.

Stephen Welch, senior analyst, equity strategies, US, on when Anthropic could enter passive indexes and what active fund managers have already invested in the company.

Alex Bryan, director of product management, equity indexes, on why indexes need to quickly reflect major IPOs and how Anthropic could affect index composition, market-cap segments, and market concentration as its public float grows.